Royal Marsden Hospital / The Royal Marsden NHS Foundation Trust

Hospital


Location: London, United Kingdom (GB) GB

ISNI: 0000000404170461

ROR: https://ror.org/034vb5t35

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

WHO 2022 classification of penile and scrotal cancers: updates and evolution (2022) Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Comperat E, et al. Journal article Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour (2022) Georgiesh T, Aggerholm-Pedersen N, Schoffski P, Zhang Y, Napolitano A, Bovee JVMG, Hjelle A, et al. Journal article Perspectives on the Risk-Stratified Treatment of Multiple Myeloma (2022) Davies FE, Pawlyn C, Usmani SZ, San-Miguel JF, Einsele H, Boyle EM, Corre J, et al. Journal article COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility (2022) Goebel H, Koeditz B, Huerta M, Kameri E, Nestler T, Kamphausen T, Friemann J, et al. Journal article Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) (2022) Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, et al. Journal article The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. (2022) Netto GJ, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, et al. Journal article, Review article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification (2022) Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, Menon S, et al. Journal article WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer (2022) Kench JG, Amin MB, Berney DM, Compérat EM, Cree IA, Gill AJ, Hartmann A, et al. Journal article, Review article The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours (2022) Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, et al. Journal article, Review article